Aurion Biotechnologies


Biotechnology company developing regenerative cell therapies for corneal endothelial disease. Focus areas include development and clinical testing of donor-derived corneal endothelial cell therapies, CMC and GMP manufacturing scale-up, quality and analytical testing, regulatory engagement, and global clinical and surgical adoption programs.

Industries

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical and biotechnology

Nr. of Employees

medium (51-250)

Aurion Biotechnologies

Bainbridge Island, Washington, United States


Products

AURN001

Investigational combination therapy composed of donor-derived human corneal endothelial cells delivered in a carrier solution containing a rho-kinase inhibitor; intended to rebuild a functional endothelial layer and restore corneal clarity following removal of diseased cells.


Services

On-site and field-facing surgical training programs and clinical site engagement to support investigator technique development and adoption during clinical development.

Expertise Areas

  • Corneal endothelial cell therapy development
  • CMC and GMP cell therapy manufacturing
  • Clinical trial management and execution
  • Regulatory strategy for regenerative medicine
  • Show More (4)

Key Technologies

  • Primary human cell isolation and culture
  • Cell therapy formulation and delivery
  • Rho-kinase inhibitor–assisted engraftment
  • GMP manufacturing for living cell therapies
  • Show More (3)

News & Updates

Report of Phase 1/2 clinical results indicating improvements in best-corrected visual acuity compared with standard of care.

Announcement that the company dosed the first patients in a pivotal Phase 3 study evaluating the lead cell therapy in patients with corneal edema secondary to endothelial dysfunction.

Announcement of completed enrollment in the pivotal Phase 3 ASTRA study for the lead cell therapy program.

Publication describing a prospective randomized trial of corneal endothelial cell therapy in subjects with corneal edema.

Media piece discussing challenges and considerations for scaling manufacturing of living cell therapies.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.